US 12312348
RET inhibitors, pharmaceutical compositions and uses thereof
granted A61PA61P1/12A61P29/00
Quick answer
US patent 12312348 (RET inhibitors, pharmaceutical compositions and uses thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE LAKE PHARMA CO., LTD.
- Grant date
- Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/12, A61P29/00, A61P35/00